{"id":"https://openalex.org/W4231453150","doi":"https://doi.org/10.1201/9781003027010-17","title":"Anti-Cancer and Anti-Angiogenic Properties of Nano-Diamino-Tetrac, A Thyroid Hormone Derivative","display_name":"Anti-Cancer and Anti-Angiogenic Properties of Nano-Diamino-Tetrac, A Thyroid Hormone Derivative","publication_year":2020,"publication_date":"2020-01-06","ids":{"openalex":"https://openalex.org/W4231453150","doi":"https://doi.org/10.1201/9781003027010-17"},"language":"en","primary_location":{"id":"doi:10.1201/9781003027010-17","doi":"https://doi.org/10.1201/9781003027010-17","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003027010-17","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Road from Nanomedicine to Precision Medicine","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W3000115911","display_name":"The Road from Nanomedicine to Precision Medicine"},"type":"book-chapter","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064680897","display_name":"Paul J. Davis","orcid":"https://orcid.org/0000-0002-6794-4917","observed_orcids":["https://orcid.org/0000-0002-6794-4917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul J. Davis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5032045966","display_name":"Shaker A. Mousa","orcid":"https://orcid.org/0000-0002-9294-015X","observed_orcids":["https://orcid.org/0000-0002-9294-015X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shaker A. Mousa","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.9279,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.78368794,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"577","last_page":"607"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10831","display_name":"Cell Adhesion Molecules Research","score":0.8403000235557556,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.13539999723434448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.012000000104308128,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.878000020980835},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.8790000081062317},{"id":"https://openalex.org/keywords/integrin-alphavbeta3","display_name":"integrin \u03b1v\u03b23","score":0.9649999737739563},{"id":"https://openalex.org/keywords/thyroid-hormone-receptor","display_name":"thyroid hormone receptor","score":0.6949999928474426},{"id":"https://openalex.org/keywords/tumor-xenografts","display_name":"tumor xenografts","score":0.8429999947547913}],"concepts":[{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.6322473287582397},{"id":"https://openalex.org/C526584372","wikidata":"https://www.wikidata.org/wiki/Q16399","display_name":"Thyroid","level":2,"score":0.5552225708961487},{"id":"https://openalex.org/C111771559","wikidata":"https://www.wikidata.org/wiki/Q66295","display_name":"Derivative (finance)","level":2,"score":0.5250135064125061},{"id":"https://openalex.org/C2780357685","wikidata":"https://www.wikidata.org/wiki/Q154357","display_name":"Nano-","level":2,"score":0.5090896487236023},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5082468390464783},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4710436165332794},{"id":"https://openalex.org/C2779761222","wikidata":"https://www.wikidata.org/wiki/Q826522","display_name":"Thyroid cancer","level":3,"score":0.4347289204597473},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.413104385137558},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4106457233428955},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37268513441085815},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.354020357131958},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.22756755352020264},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.08410552144050598},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.03845012187957764},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781003027010-17","doi":"https://doi.org/10.1201/9781003027010-17","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003027010-17","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Road from Nanomedicine to Precision Medicine","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":1,"referenced_works":["https://openalex.org/W2073347802"],"related_works":["https://openalex.org/W2109667618","https://openalex.org/W1955873957","https://openalex.org/W2557687869","https://openalex.org/W35454281","https://openalex.org/W2531169350","https://openalex.org/W2944432197","https://openalex.org/W2529622510","https://openalex.org/W2106156583","https://openalex.org/W4409090708","https://openalex.org/W2132519082"],"abstract_inverted_index":{"This":[0],"review":[1],"examines":[2],"the":[3,12,61,77,80,100,103,118,123,143],"anti-angiogenic":[4,51,120,129],"and":[5,29,45,71,113,130],"anti-cancer":[6,86,131],"properties":[7,87],"of":[8,27,53,67,79,88,95,99,102,122,146],"Nanotetrac":[9,89,125],"that":[10,38],"exploit":[11],"novel":[13],"small":[14,138],"molecule":[15,139],"receptor":[16,83,109,140],"for":[17],"thyroid":[18,81],"hormone-Nanotetrac":[19],"on":[20,110,134,142],"\u03b1v\u03b23.":[21,147],"Integrin":[22],"\u03b1v\u03b23":[23],"controls":[24],"a":[25,34,65,106,127,135],"variety":[26,66],"intracellular":[28],"transcellular":[30],"functions.":[31],"It":[32],"is":[33,39,126],"transmembrane":[35],"structural":[36],"protein":[37],"differentially":[40],"expressed/activated":[41],"in":[42,60,93,114],"tumor":[43,69],"cells":[44],"dividing":[46],"blood":[47],"vessel":[48],"cells.":[49],"The":[50,85],"activity":[52],"tetrac":[54],"was":[55,72],"confirmed":[56],"to":[57,64,74],"be":[58],"present":[59],"vascular":[62],"supply":[63],"human":[68],"xenografts":[70],"interpreted":[73],"reflect":[75],"only":[76],"disruption":[78],"hormone-integrin":[82],"interaction.":[84],"are":[90],"broadly":[91],"based":[92],"terms":[94],"mechanisms,":[96],"despite":[97],"initiation":[98],"actions":[101,121],"drug":[104],"at":[105],"single":[107],"target":[108],"integrin":[111],"\u03b1v\u03b23,":[112],"this":[115],"regard":[116],"resemble":[117],"pluralistic":[119],"drug.":[124],"prototypic":[128],"agent":[132],"focused":[133],"single,":[136],"specific":[137],"site":[141],"extracellular":[144],"domain":[145]},"counts_by_year":[{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}